Partners & Sponsors


logo insermFounded in 1964, Inserm is a public scientific and technological institute which operates under the joint authority of the French Ministries of Health and Research. Inserm is the only public research organization in France entirely dedicated to human health, and is involved in the entire range of activities from the laboratory to the patient’s bedside. Its objective is to promote the health of all by advancing knowledge about life and disease, treatment innovation, and public health research.

The cancer research center of Toulouse (CRCT) is one of the most active research center dedicated to cancer research in France, from basic discoveries to therapeutic innovation for patients. The CRCT hosts 400 members, 18 research teams and 8 technological platforms, and is located on the Oncopole campus of Toulouse, in close proximity of the Universitary Cancer Institute hospital of Toulouse (IUCT-O), to foster rapid translation from bench to bedside for best patients benefit.

Université de Montréal

Univerity Montréal LOGOFounded in 1878, the University of Montreal is the largest university in Quebec and the second largest in Canada, with over 64,000 students, including nearly 8,000 from around the world, and with more than 11,000 diplomas awarded at every university level each year. Deeply rooted in Montreal and dedicated to its international mission, the University of Montreal is one of the top universities in the French-speaking world and is ranked 29th on the list of top international institutions in Pharmacy and pharmacology by the QS World University Rankings.

Groupe de recherche universitaire sur le médicament (GRUM)

GRUM LOGOThe University Drug Research Group (GRUM) brings together researchers interested in all aspects of drug R&D at the Université de Montréal. The mission of GRUM is to support training, transdisciplinary research and technology transfer relating to drug discovery, development and evaluation.

Fondation Toulouse Cancer Santé

logo-innabiosante_bleu-minFondation Toulouse Cancer Santé is a research foundation created by 5 worldwide private companies (Amgen – GSK – Pierre Fabre – Siemens – Total) involved in research and innovation, which has been state-approved May 5th 2006, with a special endowment of ANR, the French agency for research. The aim of the Foundation is to define, promote and finance cooperative actions to develop research and industry in the life sciences and especially in oncology by supporting the highly innovative areas that are: Nano & Bio & Information Technologies and also Radiotherapy and Imaging techniques (“NBI Tech 2 Life”). Based on the Oncopole, in Toulouse, which is a campus, unique in Europe, that brings together on a single site public and private research, academic organizations, industry including pharmaceutical leaders and SMEs, medical and clinical expertise. These actors are committed to working together to achieve a single goal: more effectively fight cancer. By co-organizing the Summer School on Medicines since the first edition, Fondation Toulouse Cancer Santé shows its involvement in multidisciplinary education dedicated to students in life sciences and health, but also in technological sciences.

University of Barcelona


The University of Barcelona (UB) is the top public institution of higher education in Catalonia, catering to the needs of the greatest number of students and delivering the broadest and most comprehensive offering in higher educational courses. The UB is also the principal center of university research in Spain and has become a European benchmark for research activity, both in terms of the number of research programs it conducts and the excellence these have achieved

The UB occupies a competitive position at national (first University in Spain), European and worldwide levels in the most important ranking tables designed on a range of variables within different geographical areas. The UB holds a place among the top 200 world universities, according to the new ranking edited by the British journal The Times Higher Education (THE), maintaining its leading position in the QS World University Rankings, holding the 168th position worldwide (70th in Europe), with excellent performance in the area of life sciences and medicine (65th).

The UB is member of the most important international excellence university networks, such as the League of European Research Universities (LERU). It has overseen the creation of two campuses of international excellence: the Barcelona Knowledge Campus (BKC) and the Health University of Barcelona Campus (HUBc). The Barcelona Knowledge Campus (BKC), a project presented jointly by the UB and the Technical University of Catalonia (UPC), merges the two universities’ training, research and innovation potential on Barcelona. The project officially known as the Health Universitat de Barcelona Campus (HUBc) is dedicated to training, research and knowledge transfer, and it brings together two faculties, two university schools and six hospitals all working in various fields of health science.

Institute of Biomedicine of the University of Barcelona

logo IBUB

The Institute of Biomedicine of the University of Barcelona (IBUB) ( is a transversal research unit that brings together 40 groups from the Faculties of Biology, Pharmacy and Food Sciences and Chemistry. The IBUB was born in 2006 with the aim of identifying, beyond the classical academic structures (departments and faculties), a set of laboratories with complementary scientific activity, capable of generating synergies.

IBUB research activity is focused on drug and target discovery. The IBUB strategic plan 2022-2025 encompasses a variety of actions for the promotion of a research profile oriented towards the discovery of new biological targets and drugs susceptible to become novel generation drugs. For this purpose, there are, in addition to strong biological foundations -well endorsed by groups with extensive experience in cell and animal models suitable for molecular screening, highly recognized groups in the field of computational design of new drugs and top level laboratories in organic synthesis. These capabilities are structured in three programs: Human Genetics and Disease, Metabolism and Cell Plasticity and Drug and Target Discovery. The ultimate objective of the Institute is to ensure that intramural synergies are translated into an increase in the scale of value of their discoveries, thus providing added value to all those who are likely to be transferred to the industrial sector.

Ribeirão Preto Medical School, University of São Paulo

Brasao_Medicina_USP_Flamula1Faculdade de Medicina de Ribeirão Preto (Ribeirão Preto Medical School in Portuguese) is a medical school of the University of São Paulo (USP) located in the city of Ribeirão Preto, state of São Paulo, Brazil, founded 1952. It is considered one of the three best medical schools in the country and a premier medical research center.

Mission: “Providing excellence in higher education, providing training of health professionals with a high level of qualification and potential of leadership, based on ethical, moral, scientific and humanistic principles; training qualified researchers in its graduate programs and produce high-quality innovative research with international insertion, exploring the boundaries of knowledge, but also attentive to the society needs; continuing interaction with the public sector and with the society in order to promote qualified assistance in health and in the dissemination of new knowledge.”

Universidade de São Paulo

Logo SaoPauloThe University of São Paulo (USP) is a public University in the Brazilian state of São Paulo founded in 1934. It is the largest Brazilian public University and the country’s most prestigious educational institution, being recently ranked 51-60 worldwide in reputation by the Times Higher Education World University Rankings. USP is one of the largest institutions of higher education in Latin America, with approximately 95,000 enrolled students. Currently, it has eleven campuses, four of them in the city of São Paulo, two in São Carlos, and the remaining campuses in the cities of Bauru, Lorena, Piracicaba, Pirassununga, and Ribeirão Preto. USP is involved in teaching, research, and extension activities in all areas of knowledge. In terms of research, USP is Brazil’s largest research institution, producing more than 25% of the scientific papers published by Brazilian researchers in high quality conferences and journals- Providing innovative training and developing talent, by designing and executing programs and initiatives to improve talent and entrepreneurship considered essential factors for the growth of the sector.

Ribeirão Preto Medical School, University of São Paulo

Evotec is a life science company with a unique business model focused on delivering highly effective new therapeutics to the patients. The Company leverages its multimodality platform, the “Data-driven R&D Autobahn to Cures”, for proprietary projects and within a network of partners including Pharma, Biotech, academics, and other healthcare stakeholders. With more than 4,200 highly qualified people at 15 sites, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics. For additional information please go to and follow us on Twitter @Evotec and LinkedIn.